Cargando…

Individualizing Life Expectancy Estimates for Older Adults Using the Gompertz Law of Human Mortality

BACKGROUND: Guidelines recommend incorporating life expectancy (LE) into clinical decision-making for preventive interventions such as cancer screening. Previous research focused on mortality risk (e.g. 28% at 4 years) which is more difficult to interpret than LE (e.g. 7.3 years) for both patients a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sei J., Boscardin, W. John, Kirby, Katharine A., Covinsky, Kenneth E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180452/
https://www.ncbi.nlm.nih.gov/pubmed/25265291
http://dx.doi.org/10.1371/journal.pone.0108540
_version_ 1782337227750113280
author Lee, Sei J.
Boscardin, W. John
Kirby, Katharine A.
Covinsky, Kenneth E.
author_facet Lee, Sei J.
Boscardin, W. John
Kirby, Katharine A.
Covinsky, Kenneth E.
author_sort Lee, Sei J.
collection PubMed
description BACKGROUND: Guidelines recommend incorporating life expectancy (LE) into clinical decision-making for preventive interventions such as cancer screening. Previous research focused on mortality risk (e.g. 28% at 4 years) which is more difficult to interpret than LE (e.g. 7.3 years) for both patients and clinicians. Our objective was to utilize the Gompertz Law of Human Mortality which states that mortality risk doubles in a fixed time interval to transform the Lee mortality index into a LE calculator. METHODS: We examined community-dwelling older adults age 50 and over enrolled in the nationally representative 1998 wave of the Health and Retirement Study or HRS (response rate 81%), dividing study respondents into development (n = 11701) and validation (n = 8009) cohorts. In the development cohort, we fit proportional hazards Gompertz survival functions for each of the risk groups defined by the Lee mortality index. We validated our LE estimates by comparing our predicted LE with observed survival in the HRS validation cohort and an external validation cohort from the 2004 wave of the English Longitudinal Study on Ageing or ELSA (n = 7042). RESULTS: The ELSA cohort had a lower 8-year mortality risk (14%) compared to our HRS development (23%) and validation cohorts (25%). Our model had good discrimination in the validation cohorts (Harrell’s c 0.78 in HRS and 0.80 in the ELSA). Our predicted LE’s were similar to observed survival in the HRS validation cohort without evidence of miscalibration (Hosmer-Lemeshow, p = 0.2 at 8 years). However, our predicted LE’s were longer than observed survival in the ELSA cohort with evidence of miscalibration (Hosmer-Lemeshow, p<0.001 at 8 years) reflecting the lower mortality rate in ELSA. CONCLUSION: We transformed a previously validated mortality index into a LE calculator that incorporated patient-level risk factors. Our LE calculator may help clinicians determine which preventive interventions are most appropriate for older US adults.
format Online
Article
Text
id pubmed-4180452
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41804522014-10-07 Individualizing Life Expectancy Estimates for Older Adults Using the Gompertz Law of Human Mortality Lee, Sei J. Boscardin, W. John Kirby, Katharine A. Covinsky, Kenneth E. PLoS One Research Article BACKGROUND: Guidelines recommend incorporating life expectancy (LE) into clinical decision-making for preventive interventions such as cancer screening. Previous research focused on mortality risk (e.g. 28% at 4 years) which is more difficult to interpret than LE (e.g. 7.3 years) for both patients and clinicians. Our objective was to utilize the Gompertz Law of Human Mortality which states that mortality risk doubles in a fixed time interval to transform the Lee mortality index into a LE calculator. METHODS: We examined community-dwelling older adults age 50 and over enrolled in the nationally representative 1998 wave of the Health and Retirement Study or HRS (response rate 81%), dividing study respondents into development (n = 11701) and validation (n = 8009) cohorts. In the development cohort, we fit proportional hazards Gompertz survival functions for each of the risk groups defined by the Lee mortality index. We validated our LE estimates by comparing our predicted LE with observed survival in the HRS validation cohort and an external validation cohort from the 2004 wave of the English Longitudinal Study on Ageing or ELSA (n = 7042). RESULTS: The ELSA cohort had a lower 8-year mortality risk (14%) compared to our HRS development (23%) and validation cohorts (25%). Our model had good discrimination in the validation cohorts (Harrell’s c 0.78 in HRS and 0.80 in the ELSA). Our predicted LE’s were similar to observed survival in the HRS validation cohort without evidence of miscalibration (Hosmer-Lemeshow, p = 0.2 at 8 years). However, our predicted LE’s were longer than observed survival in the ELSA cohort with evidence of miscalibration (Hosmer-Lemeshow, p<0.001 at 8 years) reflecting the lower mortality rate in ELSA. CONCLUSION: We transformed a previously validated mortality index into a LE calculator that incorporated patient-level risk factors. Our LE calculator may help clinicians determine which preventive interventions are most appropriate for older US adults. Public Library of Science 2014-09-29 /pmc/articles/PMC4180452/ /pubmed/25265291 http://dx.doi.org/10.1371/journal.pone.0108540 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
spellingShingle Research Article
Lee, Sei J.
Boscardin, W. John
Kirby, Katharine A.
Covinsky, Kenneth E.
Individualizing Life Expectancy Estimates for Older Adults Using the Gompertz Law of Human Mortality
title Individualizing Life Expectancy Estimates for Older Adults Using the Gompertz Law of Human Mortality
title_full Individualizing Life Expectancy Estimates for Older Adults Using the Gompertz Law of Human Mortality
title_fullStr Individualizing Life Expectancy Estimates for Older Adults Using the Gompertz Law of Human Mortality
title_full_unstemmed Individualizing Life Expectancy Estimates for Older Adults Using the Gompertz Law of Human Mortality
title_short Individualizing Life Expectancy Estimates for Older Adults Using the Gompertz Law of Human Mortality
title_sort individualizing life expectancy estimates for older adults using the gompertz law of human mortality
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180452/
https://www.ncbi.nlm.nih.gov/pubmed/25265291
http://dx.doi.org/10.1371/journal.pone.0108540
work_keys_str_mv AT leeseij individualizinglifeexpectancyestimatesforolderadultsusingthegompertzlawofhumanmortality
AT boscardinwjohn individualizinglifeexpectancyestimatesforolderadultsusingthegompertzlawofhumanmortality
AT kirbykatharinea individualizinglifeexpectancyestimatesforolderadultsusingthegompertzlawofhumanmortality
AT covinskykennethe individualizinglifeexpectancyestimatesforolderadultsusingthegompertzlawofhumanmortality